1. Introduction {#sec1}
===============

Postmenopausal osteoporosis (PMOP) often occurs due to the simultaneous interaction of independent predisposing factors, including aging and continuous calcium loss \[[@B1]\]. In the developed country, 9-38% of females are affected by PMOP. It is estimated that osteoporosis-associated fractures affect one-third of women in their lifetime, which is a public health concern \[[@B2]\]. Recently, both in animal models and in humans that were affected by osteoporosis newly, evidences of the relationship between immune system and bone have been accumulated. Estrogen is a well-known regulator of the immune system and T-cell functions. Bone loss induced by estrogen deficiency in menopause is a complex effect of a multitude of pathways and cytokines working in a cooperative fashion to regulate osteoclastogenesis and osteoblastogenesis \[[@B3]--[@B6]\]. Some hypotheses have been done by previous literature data. Recent studies have shown that obesity and osteoporosis share common genetic and environmental factors. Wnt family members and Wnt inhibitor molecules were involved not only in the regulation of differentiation of multipotent mesenchymal stem cells into osteoblasts and adipocytes but also in the coordination of the switch toward osteo- or adipogenesis fate within bone marrow\[[@B7]\].

Microarray studies have been used to explore the pathogenesis of PMOP. Expression profiling with larger sample size could be obtained by integrated microarrays analysis, which contributes to identifying more accurately differentially expressed genes (DEGs) of PMOP than an individual microarray. In this study, we performed an integrated analysis of five gene expression datasets to identify the DEGs between PMOP and normal controls and explore the molecular mechanism of PMOP. Functional annotation and PPI network construction were performed to explore the biological functions of these DEGs.

Various medications, including alendronate, etidronate, risedronate, and strontium ranelate, have been employed to prevent osteoporotic fragility fractures in patients with PMOP \[[@B8]\]. MF Faienza et al. demonstrated that denosumab and romosozumab have promise in the treatment of osteoporosis and their different mechanisms of action compared to existing antiosteoporotic drugs may permit alternative strategies for osteoporosis treatment down the line \[[@B9]\]. In recent years, research of traditional Chinese medicine has confirmed that incidence of osteoporosis was closely associated with kidney. Tonics for kidney, such as Liuweidihuang (LWDH) pills, were demonstrated to exert an effect on diabetes mellitus \[[@B10]\], breast carcinoma \[[@B11]\], and protection of testes in mice \[[@B12]\]. However, few studies were focused on the effect of LWDH on human osteoporosis. In the paper of Manyu Li \[[@B13]\], it is evaluated the effects of morroniside and loganin isolated from LWDH pills on the proliferation, differentiation, and apoptosis of MC3T3-E1 (mouse embryonic osteoblast precursor cells). Morroniside and loganin were found to promote the differentiation of osteoblast precursor cells and inhibit their apoptosis, thereby reducing bone resorption. Ji-rong Ge et al. found that CLCF1 is an important gene associated with Shen-yin deficiency of PMOP and the therapeutic effects of LWDH may be mediated by upregulated expression of CLCF1 and activation of the JAK/STAT signaling pathway \[[@B14]\]. In light of the potent curative effect of LWDH, exploring the candidate genes associated with both pathogenesis of PMOP and therapeutic mechanism of LWDH on PMOP could provide clues for the mechanism of PMOP and development of novel therapeutic strategies for PMOP.

2. Materials and Methods {#sec2}
========================

2.1. Eligible Gene Expression Profiles of PMOP {#sec2.1}
----------------------------------------------

We selected gene expression datasets of PMOP on the Gene Expression Omnibus database (GEO, http://www.ncbi.nlm.nih.gov/geo) which is the largest database of high-throughput gene expression data \[[@B15]\]. Search keywords in PMOP versus normal control were "postmenopausal osteoporosis" \[MeSH Terms\] OR "postmenopausal osteoporosis" \[All Fields\]) AND "gse" \[Filter\]. Datasets that meet the following criteria will be included in our study. (1) The selected dataset must be genome-wide mRNA transcriptome data. (2) These data are derived from postmenopausal osteoporosis patients or blood samples (without drug stimulation or transfection) of patients with osteoporosis before and after LWDH pills treatment was considered. (3) Five sets of high-throughput mRNAs were screened by the standardization or original data set.

2.2. Identification of DEGs Associated with PMOP or LWDH Treatment {#sec2.2}
------------------------------------------------------------------

Firstly, we analyzed all the selected databases individually. Then, to minimize the heterogeneity among different datasets enrolled in integrated analysis, normalization and log2 transformation were performed for the raw data. Finally, an R package, metaMA package, was used to combine data from multiple microarray datasets. Individual p-values were calculated and multiple comparison correction FDR was obtained by using Benjamini and Hochberg method. Genes with FDR \< 0.05 were screened out and regarded as DEGs \[[@B16]\].

2.3. qRT-PCR Confirmation for PMOP {#sec2.3}
----------------------------------

Based on the results of high-throughput transcriptome data integration analysis, four differentially expressed genes were screened as candidate genes (PMOP versus normal control); blood samples (6 cases) from PMOP patients and healthy individuals were collected. Six blood samples were frozen at 80°C within 2 hours after blood withdrawal. After thawing the frozen samples at room temperature, 1 ml of the sample was used to perform RNA isolation with Trizol reagent (Invitrogen, China) according to the manufacturer\'s instructions. By using SuperScript® III Reverse Transcriptase (Invitrogen, China), we generated cDNA from 1*μ*g extracted RNA. With Power SYBR® Green PCR Master Mix (Applied Biosystems, USA), we performed quantitative PCR in an ABI 7500 real-time PCR system. Relative gene expression was analyzed using 2^−ΔΔCt^ method. The human GAPDH gene was used as endogenous control for mRNA expression in analysis. The sequence of the primers used in RT PCR experiment was shown in Supplementary [Table 1](#supplementary-material-1){ref-type="supplementary-material"}.

2.4. Functional Annotation of DEGs in PMOP and Common DEGs {#sec2.4}
----------------------------------------------------------

To identify the function and the potential pathway of DEGs in PMOP and 58 common DEGs, Gene Ontology (GO) classification (molecular functions, biological processes, and cellular component) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment were performed by using the online software GeneCodis (http://genecodis.cnb.csic.es/analysis) \[[@B17]\]. FDR \< 0.05 was defined as the criteria of statistical significance. Fifty-eight genes were subjected to GO enrichment and KEGG enrichment analysis using the R language (GSEABase package), P-value \< 0.01.

2.5. Protein-Protein Interaction (PPI) Network Construction {#sec2.5}
-----------------------------------------------------------

To further research the biological functions of 58 common DEGs, we constructed the PPI network by using Biological General Repository for Interaction Datasets (BioGRID) (http://thebiogrid.org/) and Cytoscape \[[@B18]\]. Based on the existing protein interaction with opposite effects on PMOP versus normal control and LWDH data of BioGRID database, Cytoscape was used to search for common and regulatory genes treatment versus PMOP. After removing the two nondifferentially expressed genes, the protein network interaction map was drawn. The network consists of nodes and edges. The nodes in the network represented the proteins and the lines represented the interactions between protein \[[@B19]\].

2.6. Target Prediction of LWDH in BATMAN-TCM Database {#sec2.6}
-----------------------------------------------------

To define the key targets of LWDH, we retrieved BATMAN-TCM database, which is the first online Bioinformatics Analysis Tool for molecular mechanism of Traditional Chinese Medicine (<http://bionet.ncpsb.org/batman-tcm/>) \[[@B20]\]. LWDH was composed of five herbs, such as ZE XIE, SHAN YAO, MU DAN PI, SHU DI HUANG, JIU YU ROU, and FU LING. We input the herb list denoted by Pinyin name of 'ZE XIE, SHAN YAO, MU DAN PI, SHU DI HUANG, JIU YU ROU, and FU LING\' with the following default parameters: predicted candidate targets (including known targets) with scores not smaller than score cutoff = 20 for each ingredient are presented and used for further bioinformatics analyses. The targets of Liuweidihuang were then obtained by a combination of the targets of ZE XIE, SHAN YAO, MU DAN PI, SHU DI HUANG, JIU YU ROU, and FU LING.

3. Results {#sec3}
==========

3.1. Differential Expression Analysis of DEGs in PMOP {#sec3.1}
-----------------------------------------------------

Four gene expression microarray datasets (GSE100609, GSE56815, GSE13850, and GSE7429) and a microarray dataset associated with therapeutic mechanism of LWDH on PMOP (GSE57273) were enrolled in our study. The clinical features of the enrolled subjects were shown in Supplementary [Table 2](#supplementary-material-1){ref-type="supplementary-material"}. In total, the ratio of PMOP versus normal control was 54:60. Compared with the normal controls, 1732 DEGs in PMOP were obtained with*p*\<0.05; among which, 918 genes were upregulated and 814 genes were downregulated. The hierarchical clustering heatmaps of DEGs in PMOP versus normal control were shown in [Figure 1](#fig1){ref-type="fig"}. Likewise, there were 1350 DEGs (322 upregulated and 1027 downregulated) in patients with PMOP versus patients after LWDH treatment. The hierarchical clustering heatmaps of DEGs in patients with PMOP versus patients after LWDH treatment were shown in [Figure 2](#fig2){ref-type="fig"}.

3.2. Functional Annotation of DEGs in PMOP {#sec3.2}
------------------------------------------

In [Figure 3](#fig3){ref-type="fig"}, GO and KEGG enrichment analysis showed that DEGs were significantly enriched in the following terms. Biological processes: regulation of transcription, DNA-dependent (*p*=4.31E-22), and signal transduction (*p*=4.44E-16). Cell component: cytoplasm (*p*=4.14E-108) and nucleus (*p*=1.06E-95). Molecular function: protein binding (*p*=4.19E-115) and metal ion binding (*p*=9.37E-27). KEGG pathway enrichment results showed that DEGs were enriched in the Osteoclast differentiation (*p*=0.00931908) and MAPK signaling pathway (*p*=2.58E-09).

3.3. qRT-PCR Confirmation for PMOP {#sec3.3}
----------------------------------

To manifest the expression of integrated analysis for PMOP, we compared the results of qRT-PCR and integrated analysis of four genes including ATF2, FBXW7, RBBP4, and RDX. In [Figure 4](#fig4){ref-type="fig"}, the expressions of ATF2, FBXW7, RDX, and RBBP4 were all consistent with our integrated analysis. These 4 selected DEGs for qRT-PCR confirmation were derived from the top 10 degrees. Based on previous studies, ATF2, FBXW7, and RDX were osteoporosis-related DEGs. Saul D \[[@B21]\] found that RBBP4 (involved in age-related memory loss) was increased in tibia callus after ovariectomy.

3.4. Coanalysis of PMOP versus Normal Control and LWDH Treatment versus PMOP {#sec3.4}
----------------------------------------------------------------------------

Combining the results of PMOP versus normal control and LWDH treatment versus PMOP, we obtained 58 common DEGs; among which, 43 genes were upregulated in PMOP versus normal control and downregulated in LWDH treatment versus PMOP; 15 genes were upregulated in LWDH treatment versus PMOP and downregulated in PMOP versus normal control. The details of these 58 common DEGs were shown in [Table 1](#tab1){ref-type="table"}.

3.5. Functional Annotation of Common DEGs {#sec3.5}
-----------------------------------------

In Supplementary [Figure 1](#supplementary-material-1){ref-type="supplementary-material"}, several GO categories of up- and downregulated common DEGs were enriched in GO terms associated with regulation of biological process (*p*=9.84E-05) and biological regulation (*p*=0.000669575) in biological process (BP), intracellular part (*p*=0.003479728) and intracellular part (*p*=0.0023611) in cellular component (CC), and protein binding (*p*=0.00011324), enzyme binding (*p*=0.00052695), and catalytic activity (*p*=0.003357531) in molecular functions (MF). The most significantly different biological process (BP) of upregulated and downregulated DEGs was the regulation of biological process. And the most significantly different molecular functions (MF) were the protein binding.

3.6. PPI Network of Common DEGs {#sec3.6}
-------------------------------

To identify potential interactions between DEGs, a PPI network was constructed. The results identified 264 nodes (genes) and 347 edges of DEGs in [Figure 5](#fig5){ref-type="fig"}. All points were differentially expressed in both groups, with blue ovals representing the common and opposite genes, diamonds representing DEGs in PMOP versus normal control, and inverted triangles representing DEGs in LWDH treatment versus PMOP, of which red represents upregulated mRNA and green represents downregulated mRNA. Among them, the higher degrees of genes were CSNK2A1 (degree=66), ATF2 (degree=33), FBXW7 (degree=26), RBBP4 (degree=23), MAP3K1 (degree=20), SRRM1 (degree =19), NCOA1 (degree=15), RDX (degree=11), and APP (degree=10), among which, the hub proteins were CSNK2A1, ATF2, and FBXW7.

3.7. Predicted Gene Targets of LWDH {#sec3.7}
-----------------------------------

Using the BATMAN-TCM database, the potential mRNA targets of the six herbs of LWDH (ZE XIE, SHAN YAO, MU DAN PI, SHU DI HUANG, JIU YU ROU, and FU LING) were predicted. There were 177, 478, 73, 42, 0, and 503 targets for ZE XIE, SHAN YAO, MU DAN PI, SHU DI HUANG, JIU YU ROU, and FU LING, respectively. Among them, there were 10 common mRNA targets (ESR1, FGFR2, MED1, PGR, PRKCB, PTGS1, PTGS2, TRIM24, VDR, and WNT4) for the six herbs. Compared with the DEGs after treatment of LWDH, ATF2, FBXW7, and RDX were significantly differentially expressed in patients after treatment, and they are also the gene targets of LWDH. And, in the PPI network, ATF2, FBXW7, and RDX were among the genes which have high degree.

4. Discussion {#sec4}
=============

Postmenopausal osteoporosis (PMOP) is a multifactorial chronic disease. With the increase of the elderly population, the incidence of osteoporosis is on the rise, which is a health issue of concern in the world \[[@B6]\]. Since the effective treatment is deficient, exploring the mechanism and finding novel therapeutic strategies for PMOP have long been an essential goal. In this study, we obtained 1732 DEGs between PMOP and normal controls by integrated microarray analysis.

Based on the function annotation analysis, we found that MAPK was a significantly enriched pathway for DEGs in PMOP. And previous study \[[@B22]\] has reported that MAPK signaling pathways are crucial in regulating osteogenesis, a genetic disorder affecting the bones. Lizhi Xing et al. \[[@B22]\] observed the upregulation of MAPK in the ovariectomy-induced bone loss. According to the functional annotation and PMOP-specific protein-protein interaction (PPI) network, four key DEGs (ATF2, FBXW7, RDX, and IGF2R) were speculated to be closely associated with PMOP.

ATF2 is a well-known osteoclastogenic transcription factor successfully identified by motif discovery analysis \[[@B23]\]. Osteoclast (also known as bone-resorbing cells) is a kind of bone tissue composition which is responsible for bone resorption. During bone resorption, the active osteoclasts secrete acidic substances and enzymes to break down the mineralized bone matrix and reduce the bone mass in this area \[[@B24]\]. In menopausal women, regulated by hormone, the activity of osteoclasts was accelerated so that the bone wall was thin. In our study, ATF2 is upregulated in PMOP group compared with normal controls, which supported previous studies. In addition, ATF2 is a hub protein of PMOP-specific PPI network which emphasized its importance in PMOP.

Radixin (RDX) is a cytoskeletal protein that may be important in linking actin to the plasma membrane. Among the ERM family members, only radixin is shown to be directly bound to the barbed ends of actin filaments. Previous studies have clarified the important roles of ERMs in various cellular processes such as epithelial morphogenesis, cell migration, and cell signal transduction \[[@B25]\]. Phosphorylated ERM protein plays an important role in cell growth, metabolism, and antiapoptosis and can promote cell migration and filamentous actin recombination and promote cell growth \[[@B26]\]. Upregulated RDX was found to be upregulated in PMOP compared with normal controls which were a potential regulator of PMOP.

FBXW7, an F-box protein component of the cullin-RING ubiquitin E3 ligase superfamilies, can recruit specific substrates to the RING E3 core through their variable carboxy-terminal protein-interaction domains. FBXW7 mediates the polyubiquitination and proteasomal degradation of active Notch. The study of Mi Yang \[[@B27]\] demonstrated that endogenous levels of FBXW7 protein were regulated by overexpression or inhibition of miR-497B195. In addition, overexpression of miR-497B195 was found to promote osteogenesis in endothelial cells of mice. In our study, FBXW7 is upregulated in PMOP group compared with normal controls which was speculated to involve with PMOP regulated by miR-497B195. Further research was needed to confirm this finding.

And previous studies evaluated the relationship between serum insulin-like growth factor-binding protein profiles and bone mineral density measurements in PMOP \[[@B28]\]. Insulin-like growth factor-binding protein, also known as IGFBP, serves as a carrier protein for insulin-like growth factor, which binds to insulin-like growth factor 2 receptor (IGF2R) \[[@B29]\]. The serum insulin-like growth factor-binding protein-2 ratio in postmenopausal women with osteoporosis was significantly higher (p \< 0.02) than that in normal healthy postmenopausal women, but the serum insulin-like growth factor binding protein-3 ratio in women with osteoporosis was significantly lower (p \< 0.01). Wuster et al. suggested that there is a positive correlation between bone mineral density and IGFBP-3 in postmenopausal women with osteoporosis \[[@B30]\].

Furthermore, three upregulated genes (ATF, RDX, and FBXW7) were found to be downregulated in patients with PMOP after treatment of LWDH in this present study. Based on the BATMAN-TCM database, the potential targets of four herbs of "LWDH (ZE XIE, SHAN YAO, MU DAN PI, SHU DI HUANG and FU LING)" were predicted. All the above three genes (ATF, RDB, and FBXW7) were predicted targets of LWDH which provided evidence for our finding.

5. Conclusion {#sec5}
=============

Taken together, MAPK was found to be associated with PMOP. Four genes (ATF, RDB, FBXW7, and IGF2R) might be potential regulators and biomarkers of PMOP. Moreover, three genes (ATF, RDB, and FBXW7) were speculated to be closely associated with both the pathogenesis of PMOP and the therapeutic mechanism of LWDH for PMOP. Our finding contributed to providing clues for exploring mechanism and novel strategy of drug design for PMOP. However, small sample size of RT-PCR was a limitation for our study, and further research with large sample size was needed to confirm this conclusion.
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**Supplementary [Figure 1](#fig1){ref-type="fig"}. GO functional enrichment of 58 common DEGs**. A: biological progress; B: cellular component; and C: molecular function. The y-axis represented GO terms and the x-axis shows represented counts of DEmRNAs enriched in GO terms.**Supplementary Table**1. The primers of selected mRNAs (ATF2, FBXW7, RBBP4, and RDX).**Supplementary Table**2. The clinical features of the enrolled subjects from four datasets (GSE100609, GSE56815, GSE13850, and GSE7429).

###### 

Click here for additional data file.

![**The heatmap of DEGs in PMOP versus normal control**. Row and column were used to represent DEGs and datasets. The color scale represented the expression levels of DEGs.](BMRI2019-1907906.001){#fig1}

![**The heatmap of DEGs in LWDH treatment versus PMOP**. Row and column were used to represent DEGs and datasets. The color scale represented the expression levels of DEGs.](BMRI2019-1907906.002){#fig2}

![**Go and KEGG functional enrichment of DEGs in PMOP**. (a) Biological progress; (b) cellular component; (c) molecular function; and (d) KEGG functional enrichment. The y-axis represented GO and KEGG terms and the x-axis shows represented counts of DEmRNAs enriched in GO and KEGG terms.](BMRI2019-1907906.003){#fig3}

![**qRT-PCR verification results for PMOP**. The X-axis indicated eight selected DEGs and the Y-axis indicated log 2 (fold change) for qRT-PCR results.](BMRI2019-1907906.004){#fig4}

![**Protein-protein network of 58 common DEGs**. All points were differentially expressed in both groups; the blue ovals represented the common and oppositely expressed genes; the diamonds represented the differentially expressed genes in PMOP versus normal control; the inverted triangle represents the differentially expressed genes in LWDH treatment versus PMOP, of which red represented upregulated mRNA and green represented downregulated mRNA.](BMRI2019-1907906.005){#fig5}

###### 

Coexpressed and opposite trend of DEGs in the two groups.

  **Id**   **Symbol**   **case vs normal**   **before vs after**                 
  -------- ------------ -------------------- --------------------- ------------- ------
  2181     ACSL3        0.044463305          up                    5.81E-05      down
  23519    ANP32D       0.031671352          up                    0.00020335    down
  1386     ATF2         0.015288615          up                    0.000105124   down
  892      CCNC         0.037220624          up                    4.23E-05      down
  1370     CPN2         0.009788448          up                    1.57E-05      down
  1457     CSNK2A1      0.029560249          up                    0.00035395    down
  79848    CSPP1        0.011683224          up                    1.11E-05      down
  6374     CXCL5        0.027209429          up                    6.23E-05      down
  80777    CYB5B        0.000178896          up                    0.000622171   down
  23741    EID1         0.043185211          up                    0.000455124   down
  9669     EIF5B        0.014971999          up                    0.00042694    down
  23085    ERC1         0.032754729          up                    0.000160588   down
  30001    ERO1L        0.0154858            up                    0.000625767   down
  55294    FBXW7        0.037818674          up                    0.000138841   down
  2914     GRM4         0.023673494          up                    0.000502142   down
  2935     GSPT1        0.004988472          up                    2.63E-05      down
  3482     IGF2R        0.043016644          up                    0.000342073   down
  7850     IL1R2        0.025284329          up                    3.93E-06      down
  9929     JOSD1        0.013589301          up                    0.000203472   down
  51621    KLF13        0.020717689          up                    7.15E-05      down
  4214     MAP3K1       0.022243844          up                    8.40E-05      down
  79649    MAP7D3       0.003259237          up                    0.000418951   down
  158747   MOSPD2       0.001561148          up                    0.000121954   down
  7703     PCGF2        0.013528324          up                    6.33E-05      down
  5294     PIK3CG       0.001627058          up                    0.00030047    down
  59338    PLEKHA1      0.049102137          up                    0.000452568   down
  59339    PLEKHA2      0.007489418          up                    1.26E-05      down
  133619   PRRC1        0.022743976          up                    0.00052731    down
  5928     RBBP4        0.00010116           up                    4.70E-05      down
  5962     RDX          0.049953292          up                    0.000486787   down
  55680    RUFY2        0.001194843          up                    0.000266002   down
  5552     SRGN         0.009208736          up                    0.000209717   down
  6717     SRI          0.037181628          up                    0.000508307   down
  10250    SRRM1        0.000952409          up                    6.51E-05      down
  9262     STK17B       0.016461631          up                    3.91E-05      down
  26136    TES          0.000594943          up                    0.000259901   down
  10959    TMED2        0.046585899          up                    0.000567562   down
  54765    TRIM44       0.000191712          up                    0.000565748   down
  389898   UBE2NL       0.013171719          up                    0.00048327    down
  54904    WHSC1L1      0.020186972          up                    1.24E-05      down
  81555    YIPF5        0.018233854          up                    0.000196894   down
  10472    ZNF238       0.002670727          up                    7.55E-05      down
  7639     ZNF85        0.028282272          up                    0.000212913   down
  55811    ADCY10       0.012001458          down                  0.000502024   up
  55009    C19orf24     0.006292312          down                  0.000610074   up
  51372    CCDC72       0.000667113          down                  0.00060282    up
  2323     FLT3LG       0.017012385          down                  0.000637474   up
  2794     GNL1         0.012495179          down                  0.000573231   up
  55716    LMBR1L       0.001157605          down                  0.000600187   up
  8648     NCOA1        0.016190136          down                  0.000192176   up
  51070    NOSIP        0.008546637          down                  0.000285444   up
  54623    PAF1         0.034489911          down                  0.000236501   up
  51177    PLEKHO1      0.036853037          down                  0.000331093   up
  5439     POLR2J       0.026864334          down                  0.000213443   up
  6165     RPL35A       0.041712982          down                  0.00055368    up
  6827     SUPT4H1      0.016431549          down                  0.000265733   up
  54958    TMEM160      0.022504594          down                  0.000255735   up
  389136   VGLL3        0.049059686          down                  0.000604032   up
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